(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | (Q1)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -442.99%-465.91K | 9.23%-17.53K | 164.10%37.9K | -7,071.64%-237.45K | -2,210.15%-248.83K | -85.8K | 60.68%-19.31K | -59.13K | 3.41K | -10.77K |
Net income from continuing operations | -948.97%-1.32M | -1,722.45%-660.09K | -297.08%-231.21K | -832.19%-261.16K | -4,724.43%-168.86K | ---125.96K | 27.72%-36.22K | ---58.23K | ---28.02K | ---3.5K |
Operating gains losses | --3.48K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset impairment expenditure | --192.26K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | 1,542.60%659.67K | 2,542.33%446.82K | 29,968.37%269.11K | -24.55%23.71K | -999.86%-79.97K | --40.16K | 1,591.00%16.91K | ---901 | --31.42K | ---7.27K |
-Change in receivables | -746.97%-28.49K | -802.27%-10.32K | -388.19%-13.81K | 422.32%5.27K | -2,307.25%-9.63K | ---3.36K | -90.67%-1.14K | ---2.83K | --1.01K | ---400 |
-Change in prepaid assets | ---- | ---- | ---- | --0 | -3,211.26%-100K | ---- | ---- | ---- | --3.02K | ---3.02K |
-Change in payables and accrued expense | 1,481.11%688.16K | 2,432.07%457.14K | 9,392.48%182.92K | -32.68%18.44K | 870.14%29.66K | --43.52K | 1,028.38%18.05K | --1.93K | --27.39K | ---3.85K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -442.99%-465.91K | 9.23%-17.53K | 164.10%37.9K | -7,071.64%-237.45K | -2,210.15%-248.83K | ---85.8K | 60.68%-19.31K | ---59.13K | --3.41K | ---10.77K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -4.86M | 1.33M | 0 | 0 | ||||||
Net PPE purchase and sale | ---190.62K | ---155.62K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | ---4.67M | --1.49M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---4.86M | --1.33M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,214.95%5.51M | -743.55%-1.89M | 7.4M | 0 | 0 | 419.4K | 938.09%293.33K | 0 | 80K | 46.07K |
Net issuance payments of debt | ---1.1M | -5,250.00%-4.28M | --3.18M | ---- | ---- | --0 | ---80K | --0 | ---- | ---- |
Net common stock issuance | 1,580.68%6.59M | 540.79%2.39M | --4.19M | --0 | --0 | --391.83K | 1,166.66%373.33K | --0 | --0 | --18.5K |
Proceeds from stock option exercised by employees | 6.99%29.5K | --0 | --29.5K | --0 | --0 | --27.57K | --0 | --0 | --0 | --27.57K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,214.95%5.51M | -743.55%-1.89M | --7.4M | --0 | --0 | --419.4K | 938.09%293.33K | --0 | --80K | --46.07K |
Net cash flow | ||||||||||
Beginning cash position | 153.76%550.56K | 372.39%1.31M | -80.85%64.28K | 19.61%301.73K | 153.76%550.56K | --216.96K | -4.99%276.54K | --335.67K | --252.26K | --216.96K |
Current changes in cash | -44.73%184.37K | -308.53%-571.41K | 2,200.59%1.24M | -384.70%-237.45K | -804.87%-248.83K | --333.6K | 469.75%274.02K | ---59.13K | --83.41K | --35.3K |
End cash Position | 33.49%734.93K | 33.49%734.93K | 372.39%1.31M | -80.85%64.28K | 19.61%301.73K | --550.56K | 153.76%550.56K | --276.54K | --335.67K | --252.26K |
Free cash from | -665.14%-656.52K | -796.65%-173.14K | 104.91%2.9K | -7,071.64%-237.45K | -2,210.15%-248.83K | ---85.8K | 50.63%-19.31K | ---59.13K | --3.41K | ---10.77K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.